APA (7th ed.) Citation

Schmitt-Hoffner, F., van Rijn, S., Toprak, U., Mauermann, M., Rosemann, F., Heit-Mondrzyk, A. C., . . . Kool, M. (2021). FOXR2 stabilizes MYCN protein and identifies non-MYCN-amplified neuroblastoma patients with unfavorable outcome. Journal of clinical oncology, 39(29), . https://doi.org/10.1200/JCO.20.02540

Chicago Style (17th ed.) Citation

Schmitt-Hoffner, Felix, et al. "FOXR2 Stabilizes MYCN Protein and Identifies Non-MYCN-amplified Neuroblastoma Patients with Unfavorable Outcome." Journal of Clinical Oncology 39, no. 29 (2021). https://doi.org/10.1200/JCO.20.02540.

MLA (9th ed.) Citation

Schmitt-Hoffner, Felix, et al. "FOXR2 Stabilizes MYCN Protein and Identifies Non-MYCN-amplified Neuroblastoma Patients with Unfavorable Outcome." Journal of Clinical Oncology, vol. 39, no. 29, 2021, https://doi.org/10.1200/JCO.20.02540.